PRO 140 (9CI)

Ibalizumab

Polyethylene glycol 12-hydroxystearate

Iratumumab

Pritumumab

Glycosphingolipids, soya (15C)

Elsilimomab

Immunoglobulin G1, anti-(human epidermal growth factor receptor HER2) (human-Mus musculus monoclonal SHR-1805 γ1-chain), complex with human-Mus musculus monoclonal SHR-1805 κ-chain, dimer, thioether with N-[6-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-1-oxohexyl]glycylglycyl-L-phenylalanyl-N-[[(1R)-1-cyclopropyl-2-[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-1-yl]amino]-2-oxoethoxy]methyl]glycinamide (ACI)

DNA, d(G-sp-G-sp-G-G-G-A-C-G-A-T-C-G-T-C-G-sp-G-sp-G-sp-G-sp-G-sp-G) (9CI)

17-Dimethylaminoethylamino-17-demethoxygeldanamycin

Isoscabertopin

Teneliximab

Rovelizumab

Matuzumab

Immunoglobulin G1 [de-449-lysine], anti-(human tumor necrosis factor superfamily protein TNFSF15) (human monoclonal TEV-48574 γ1-chain), disulfide with human monoclonal TEV-48574 λ-chain, dimer (ACI)

9-[4-[[Bis[2-[[2-(ethylthio)ethyl]thio]ethyl]amino]methyl]-2-(trifluoromethyl)phenyl]-6-(1-piperidinyl)-3H-xanthen-3-one (ACI)

2-(3-Pyridinyl)naphth[2,3-d]oxazole-4,9-dione (ACI)

4-(Dimethylamino)-N-[3-[[2-[(4-oxo-4H-1-benzopyran-7-yl)oxy]acetyl]amino]phenyl]benzamide (ACI)

Immunoglobulin G1 [234-alanine,235-alanine,329-alanine], anti-(human tumor necrosis factor superfamily protein TNFSF15) (human monoclonal PRA023 γ1-chain), disulfide with human monoclonal PRA023 κ-chain, dimer (ACI)

Immunoglobulin G1, anti-(human insulin-like growth factor I receptor) (human-Mus musculus monoclonal VRDN-001 γ1-chain), disulfide with human-Mus musculus monoclonal VRDN-001 κ-chain, dimer (ACI)